Neonatal screening for cystic fibrosis: A comparison of two strategies for case detection in 1.2 million babies
- 1 December 1995
- journal article
- Published by Elsevier in The Journal of Pediatrics
- Vol. 127 (6), 965-970
- https://doi.org/10.1016/s0022-3476(95)70040-4
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Delayed diagnosis of cystic fibrosis in children with a rare genotype (ΔF508/R117H)Journal of Paediatrics and Child Health, 1995
- Neonatal Screening for Cystic Fibrosis: Addition of Molecular Diagnostics to Increase SpecificityBiochemical Medicine and Metabolic Biology, 1993
- Newborn screening for cystic fibrosis: Its evolution and a review of the current situationScreening, 1993
- Neonatal screening strategy for cystic fibrosis using immunoreactive trypsinogen and direct gene analysis.BMJ, 1991
- Abnormal frequency of ΔF508 mutation in neonatal transitory hypertrypsinaemiaThe Lancet, 1991
- Gene amplification directly from Guthrie blood spotsThe Lancet, 1990
- Pancreatic Function in Infants Identified as Having Cystic Fibrosis in a Neonatal Screening ProgramNew England Journal of Medicine, 1990
- Survival and clinical outcome in patients with cystic fibrosis, with or without neonatal screeningThe Journal of Pediatrics, 1989
- DIAGNOSIS OF CYSTIC FIBROSISThe Lancet, 1987
- Cystic fibrosis screening by dried blood spot trypsin assay: Results in 75,000 newborn infantsThe Journal of Pediatrics, 1983